|
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
RECRUITINGSponsored by Centro Cardiologico Monzino
Actively Recruiting
SponsorCentro Cardiologico Monzino
Started2023-06-19
Est. completion2026-06-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06341166
Summary
This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * age ≥ 18 years * Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views Exclusion Criteria: * age\< 18 years * coexistence of other cardiomyopathies or other ≥ moderate valve diseases * scarce acoustic transthoracic echocardiographic window * usual contraindications for cardiac magnetic resonance
Conditions2
Heart DiseaseMitral Valve Prolapse
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorCentro Cardiologico Monzino
Started2023-06-19
Est. completion2026-06-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06341166